9 research outputs found

    The backbone RMSD to the X-ray structure of the parental peptide Melan-A<sub>26–35</sub>A27L (ELAGIGILTV) or to the predicted structure of the parental peptide Melan-A<sub>26–35</sub> (peptide 22; EAAGIGILTV) versus the experimental cross-reactivity: no correlation can be observed.

    No full text
    <p>The backbone RMSD to the X-ray structure of the parental peptide Melan-A<sub>26–35</sub>A27L (ELAGIGILTV) or to the predicted structure of the parental peptide Melan-A<sub>26–35</sub> (peptide 22; EAAGIGILTV) versus the experimental cross-reactivity: no correlation can be observed.</p

    Predicted cross-reactivity as a function of the similarity to the different descriptors in the three models obtained for the entire data set (23 molecules).

    No full text
    <p>The three different models are indicated by circles, triangles and squares, respectively. The descriptors are colored according to cross-reactivity: cross-reactive descriptors, i.e. peptides 22 and 25, are colored green and non-cross-reactive descriptors, i.e. peptides 103 and 105/107/110, are colored red. It can be observed that an increased similarity to the cross-reactive peptides increases the predicted cross-reactivity, while an increase in similarity to one of the non-cross-reactive peptides decreases the predicted cross-reactivity.</p

    The binding affinity of ELS and ELT for HLA A2 was evaluated in competition assays.

    No full text
    <p>(See Material and Methods.) The average of two independent, but very similar, results is shown: the two analog peptides competed with very similar efficiency indicating that their affinities for HLA A2 were practically indistinguishable. Note that values are relative to specific lysis with the Influenza Matrix peptide FluMa<sub>58–66</sub> by the FluMa<sub>58–66</sub> specific clone and can therefore take values >100%, see Material and Methods.</p
    corecore